U.S. Capital Wealth Advisors, LLC Amgen Inc Transaction History

U.S. Capital Wealth Advisors, LLC

$3.21 Billion
Q2 2025

A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 19,156 shares of AMGN stock, worth $5.46 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

19,156

Previous 17,771 7.79%

Holding current value

$5.46 Million

Previous $5.54 Million 3.4%

% of portfolio

0.17%

Previous 0.18%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 14, 2025	BUY	$262.28 - $309.85 $363,257 - $429,142	1,385 Added 7.79%	19,156 $5.35 Million
Q1 2025 Apr 29, 2025	BUY	$258.59 - $327.36 $333,839 - $422,621	1,291 Added 7.83%	17,771 $5.54 Million
Q4 2024 Jan 24, 2025	SELL	$258.78 - $328.31 $1.44 Million - $1.83 Million	-5,561 Reduced 25.23%	16,480 $4.3 Million
Q3 2024 Oct 22, 2024	BUY	$309.38 - $337.38 $79,201 - $86,369	256 Added 1.18%	22,041 $7.1 Million
Q2 2024 Jul 11, 2024	BUY	$262.75 - $319.31 $23,384 - $28,418	89 Added 0.41%	21,785 $6.81 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $1.33 Million - $1.6 Million	4,931 Added 29.41%	21,696 $6.17 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $941,998 - $1.06 Million	-3,684 Reduced 18.02%	16,765 $4.83 Million
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $21,427 - $26,603	-98 Reduced 0.48%	20,449 $5.5 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $30,640 - $36,231	143 Added 0.7%	20,547 $4.56 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $171,826 - $209,427	761 Added 3.87%	20,404 $4.93 Million
Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $91,612 - $116,404	-400 Reduced 2.0%	19,643 $5.16 Million
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $465,305 - $524,779	2,073 Added 11.54%	20,043 $4.52 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $9,459 - $10,526	-41 Reduced 0.23%	17,970 $4.37 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $2.53 Million - $2.8 Million	-11,527 Reduced 39.02%	18,011 $4.36 Million
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $404,720 - $463,166	-2,035 Reduced 6.45%	29,538 $6.65 Million
Q3 2021 Nov 01, 2021	BUY	$212.27 - $248.7 $6.7 Million - $7.85 Million	31,573 New	31,573 $6.71 Million

Others Institutions Holding AMGN

# of Institutions

3,273

Shares Held

434M

Call Options Held

7.34M

Put Options Held

7.36M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.

Account

U.S. Capital Wealth Advisors, LLC Amgen Inc Transaction History